AR049660A1 - Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores, usos y procedimiento de preparacion - Google Patents

Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores, usos y procedimiento de preparacion

Info

Publication number
AR049660A1
AR049660A1 ARP050102757A ARP050102757A AR049660A1 AR 049660 A1 AR049660 A1 AR 049660A1 AR P050102757 A ARP050102757 A AR P050102757A AR P050102757 A ARP050102757 A AR P050102757A AR 049660 A1 AR049660 A1 AR 049660A1
Authority
AR
Argentina
Prior art keywords
formulations
propellant
aerosol
agents
propulsing
Prior art date
Application number
ARP050102757A
Other languages
English (en)
Inventor
Christel Schmelzer
Arne Froemder
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35169696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR049660(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004032322A external-priority patent/DE102004032322A1/de
Priority claimed from DE200510023334 external-priority patent/DE102005023334A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR049660A1 publication Critical patent/AR049660A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente se refiere a formulaciones de gases propulsores que contienen al menos un principio activo suspendido. Reivindicacion 1: Suspension en aerosol con contenido en agentes propulsores que contiene partículas de principio activo con agua unida químicamente, al menos 85% en peso de un gas propulsor o de una mezcla de gases propulsores con TG 227 ea y/o TG 134 a o en mezcla con al menos otro gas propulsor, elegido del grupo consistente en propano, butano, pentano, dimetiléter, CHClF2, CH2F2, CF3CH3, isobutano, isopentano y neopentano, caracterizado porque la suspension en aerosol contiene, junto al agua unida químicamente, al principio activo más agua libre.
ARP050102757A 2004-07-02 2005-07-01 Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores, usos y procedimiento de preparacion AR049660A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004032322A DE102004032322A1 (de) 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
DE200510023334 DE102005023334A1 (de) 2005-05-17 2005-05-17 Aeorosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel

Publications (1)

Publication Number Publication Date
AR049660A1 true AR049660A1 (es) 2006-08-23

Family

ID=35169696

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050102757A AR049660A1 (es) 2004-07-02 2005-07-01 Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores, usos y procedimiento de preparacion

Country Status (19)

Country Link
US (1) US8357352B2 (es)
EP (1) EP1809243B2 (es)
JP (1) JP5209963B2 (es)
KR (1) KR101297061B1 (es)
AR (1) AR049660A1 (es)
AU (1) AU2005259523B2 (es)
BR (1) BRPI0512878A (es)
CA (1) CA2571519C (es)
DK (1) DK1809243T4 (es)
EA (1) EA013428B1 (es)
EC (1) ECSP077126A (es)
ES (1) ES2391563T5 (es)
IL (1) IL180461A0 (es)
MX (1) MXPA06015204A (es)
NO (1) NO20070373L (es)
NZ (1) NZ552869A (es)
PL (1) PL1809243T5 (es)
TW (1) TWI377943B (es)
WO (1) WO2006002840A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA013428B1 (ru) 2004-07-02 2010-04-30 Бёрингер Ингельхайм Интернациональ Гмбх РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
GB2442745B (en) 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
GB2442746B (en) * 2006-10-13 2011-04-06 At & T Corp Method and apparatus for acoustic sensing using multiple optical pulses
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP3695835A1 (en) * 2009-02-03 2020-08-19 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
EP2662472B1 (de) 2009-03-31 2019-02-27 Boehringer Ingelheim International Gmbh Verfahren zur Beschichtung einer Oberfläche eines Bauteils
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
UA107097C2 (en) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Dispenser
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013127738A1 (de) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Neue treibgashaltige tiotropium-formulierung
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
DK3139983T3 (da) 2014-05-07 2023-09-11 Boehringer Ingelheim Int Beholder og indikatoranordning, samt forstøver
JP6580070B2 (ja) 2014-05-07 2019-09-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 容器、ネブライザ、及び使用
US10322198B2 (en) 2016-07-08 2019-06-18 The Procter & Gamble Company Freshening compositions comprising isopropyl myristate

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8824804D0 (en) 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5919435A (en) 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
AU680227B2 (en) 1992-12-09 1997-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
JP3588113B2 (ja) 1993-04-30 2004-11-10 ミネソタ マイニング アンド マニュファクチャリング カンパニー エアゾール缶用シール構成
EP0708805B9 (en) 1993-07-15 2012-03-21 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
EA000889B1 (ru) 1995-04-14 2000-06-26 Глаксо Веллкам Инк. Дозирующий ингалятор дипропионата беклометазона
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
GB2326334A (en) 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
JP3801348B2 (ja) 1997-07-28 2006-07-26 株式会社ヴァレオサーマルシステムズ レシーバタンク
JP4117059B2 (ja) * 1998-02-10 2008-07-09 東洋エアゾール工業株式会社 高濃度粉末エアゾール製品
US6423298B2 (en) 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
NZ509489A (en) 1998-08-04 2002-10-25 Jago Res A Medicinal aerosol formulations comprising cromoglycic acid and/or nedocromil
US5955958A (en) † 1998-10-05 1999-09-21 Lu; Kai Holiday candy jar with light and sound effects
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
US6739333B1 (en) * 1999-05-26 2004-05-25 Boehringer Ingelheim Pharma Kg Stainless steel canister for propellant-driven metering aerosols
GB0002798D0 (en) 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
WO2002005785A1 (en) * 2000-07-18 2002-01-24 Aeropharm Technology Incorporated Modulated release therapeutic aerosols
CA2417973A1 (en) * 2000-08-04 2002-02-14 Longwood Pharmaceutical Research, Inc. Formulations of mometasone and a bronchodilator for pulmonary administration
DE10043509A1 (de) 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
PT1414508E (pt) 2001-06-26 2011-07-08 Norton Healthcare Ltd Um accionador de aerossol melhorado
KR20040081753A (ko) 2002-02-01 2004-09-22 아스트라제네카 아베 흡입용 조성물
HUE044926T2 (hu) 2002-03-01 2019-11-28 Chiesi Farm Spa Szuperfinom formoterolkészítmény
EP1340492A1 (en) 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
DE10214263A1 (de) † 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
MXPA05005439A (es) 2002-11-22 2005-08-03 Lilly Co Eli Moduladores del receptor de vitamina d.
CN1761455A (zh) * 2003-03-20 2006-04-19 贝林格尔·英格海姆药物公司 采用氢－氟－烷作为推进剂的计量剂量吸入器制剂
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
DE102004032322A1 (de) 2004-07-02 2006-02-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
EA013428B1 (ru) 2004-07-02 2010-04-30 Бёрингер Ингельхайм Интернациональ Гмбх РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
MX2007007378A (es) 2004-12-17 2007-08-14 Cipla Ltd Compuestos y composiciones farmaceuticas.
DE102006053374A1 (de) 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel

Also Published As

Publication number Publication date
EP1809243B1 (de) 2012-07-18
NZ552869A (en) 2010-06-25
TW200612945A (en) 2006-05-01
NO20070373L (no) 2007-01-31
EA013428B1 (ru) 2010-04-30
JP2008504325A (ja) 2008-02-14
ECSP077126A (es) 2007-02-28
JP5209963B2 (ja) 2013-06-12
EA200700042A1 (ru) 2007-08-31
TWI377943B (en) 2012-12-01
PL1809243T3 (pl) 2013-05-31
AU2005259523B2 (en) 2011-06-09
DK1809243T3 (da) 2012-10-15
MXPA06015204A (es) 2007-03-15
WO2006002840A2 (de) 2006-01-12
US8357352B2 (en) 2013-01-22
EP1809243B8 (de) 2013-02-27
PL1809243T5 (pl) 2022-12-27
CA2571519A1 (en) 2006-01-12
US20060002863A1 (en) 2006-01-05
ES2391563T5 (es) 2022-10-26
WO2006002840A8 (de) 2012-11-08
IL180461A0 (en) 2007-06-03
KR101297061B1 (ko) 2013-08-19
EP1809243A2 (de) 2007-07-25
CA2571519C (en) 2013-05-14
DK1809243T4 (da) 2022-09-05
EP1809243B2 (de) 2022-06-08
WO2006002840A3 (de) 2006-11-16
ES2391563T3 (es) 2012-11-27
BRPI0512878A (pt) 2008-04-15
AU2005259523A1 (en) 2006-01-12
KR20070042166A (ko) 2007-04-20

Similar Documents

Publication Publication Date Title
AR049660A1 (es) Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores, usos y procedimiento de preparacion
CO6150087A2 (es) Formulaciones de lociones en aerosol
GB1033299A (en) Pressurized compositions
AR011611A1 (es) Composiciones en gel postespumante
CR8428A (es) Agente endoparasiticidas para la administracion topica
ES2147913T3 (es) Uso de propilenoxidopolioles iniciados con toluilendiamina en espumas rigidas de poliuretano.
BRPI0414883A (pt) composição, concentrado de composição, e, composições alcoólicas desinfetante e semelhante a gel
SV2006002215A (es) Nuevos herbicidas ref. 70471/sv
GT200600023A (es) Combinacion de xolair con agente inmunosupresivo
PE20080765A1 (es) Formas de dosificacion farmaceutica
BR0011489A (pt) Composições formadoras de pelìcula compreendendo amidos modificados e iota-carragenano e processos para a fabricação de cápsulas macias usando as mesmas
BR112013006237A2 (pt) composição extintora de fogo, que gera substância extintora de fogo através de reação química dos ingredientes em alta temperatura
WO2007085902A3 (en) Foamable composition combining a polar solvent and a hydrophobic carrier
CO5070580A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
ATE179596T1 (de) Neue schaumzusammensetzungen, insbesondere zur rektalen anwendung, sowie davon erhaltene schäume
BR112015024644A2 (pt) dispositivo aerossol, processo para a lavagem a seco e o tratamento cosmético das matérias queratínicas e uso da composição cosmética pulverizada a partir do dispositivo aerossol
ES2178479T3 (es) Concentrado de principio activo con formoterol, apto para el almacenamiento.
PA8481601A1 (es) Desnaturalizantes para las sales aminas simpaticomimeticas
WO2007055905A3 (en) Compositions and methods of vascular injury repair
PA8543901A1 (es) Producto cosmetico de dos fases de bolita (roll-on)
ECSP066912A (es) Formulaciones de dispersiones sólidas de acetato de bazedoxifeno
ES2595354T3 (es) Sistema de polímero de silicona-sílice
BR0111630A (pt) Espiral para inseto
CR9364A (es) Agentes endoparasiticidas
AR060072A1 (es) Aerosoles dosificadores para la administracion de preparaciones farmaceuticas

Legal Events

Date Code Title Description
FB Suspension of granting procedure